Aaron Ciechanover: Medizin nach Maß. Die Chancen und Risiken ­individualisierter Therapien

In the organizer's words:

The small protein ubiquitin is important in the degradation of cellular waste. Biochemist Aaron Ciechanover discovered how cells use it to regulate the disposal of waste products. This process is important in the development of serious diseases such as cancer and disorders of the immune system. This offers the opportunity to develop new personalized medicines based on individual patient DNA profiles. However, this medical progress also raises bioethical questions.
The Nobel Prize winner discusses the dimensions and risks of customized medicine in a captivating way and reports on the success of new therapies.

Aaron Ciechanover, born in Haifa, is Professor of Medicine at the Technion - Israel Institute of Technology. He is a member of numerous scientific institutions. He was awarded the Nobel Prize in Chemistry in 2004 for his discovery of ubiquitin-controlled protein degradation.

Language: English

Price information:

Surcharge at the Box Office